Try our mobile app

Switch to company model in classical logic    *

General information

Country: UNITED STATES

Sector: Medical Devices

Insulet Corporation operates as a medical device company. The Company develops, manufactures, and markets an insulin infusion system for people with insulin-dependent diabetes. Insulet markets its products in the United Kingdom, Canada, and United States.
Website: insulet.com



Growth: Good revenue growth rate 29.8%, there is acceleration compared to average historical growth rates 26.7%. The revenue growth dynamics is stable Site traffic for the last 3 months showed a change of -17.5%

Profitability: LTM EBITDA margin is positive, +19.9%. On average the margin is improving unsteadily. Gross margin is high, +72.2%. In the last quarter the company beat the estimated EPS, +109.1%. The company was ahead of estimated EPS in 60% of quarters (showing a gain of -$0.08 per share on average)

Cash Flow Generation: Dividend yield for the last twelve months 0.0%. Free cash flow yield 1.3% (LTM)

Undervaluation: Fundamental value created in LTM (estimate)


Entry Point: Share price is 112.3% higher than minimum and 23.1% lower than maximum for the last 3 years

AI Insight: the companies with similar growth trajectories, EBITDA margin, industries and geography on average are valued 3.9x by EV / Sales multiple , the company can be 49.4% overvalued

Insiders: For the last 3 months insiders sold company shares on $0.2 mln (-0.001% of cap.)

Key Financials (Download financials)

Ticker: PODD
Share price, USD:  (0.0%)271.31
year average price 297.30  


year start price 283.08 2025-02-08

min close price 237.06 2025-03-10

max close price 352.82 2025-09-09

current price 271.31 2026-02-07
Common stocks: 70 367 000

Dividend Yield:  0.0%
FCF Yield LTM: 1.3%
EV / LTM EBITDA: 38.5x
EV / EBITDA annualized: 32.9x
Last revenue growth (y/y):  +29.8%
Last growth of EBITDA (y/y):  +31.3%
Historical revenue growth:  +26.7%
Historical growth of EBITDA:  +74.6%
EV / Sales: 7.7x
Margin (EBITDA LTM / Revenue): 19.9%
Fundamental value created in LTM:
Market Cap ($m): 19 091
Net Debt ($m): 257
EV (Enterprise Value): 19 348
Price to Book: 13.8x

Revenue and EBITDA

Quarterly values ($m)

Change (y/y)

Cash Flow

FCF ($m)

Net Debt / Cash and Equivalents ($m)

Share price and dividends (Download history)

Share price

Payment USD per share

Multiple and potential

EV / Sales

Potential dynamics

News


2026-01-02zacks.com

Is it the Right Time to Add Insulet Stock to Your Portfolio?

2025-12-26zacks.com

3 Reasons Growth Investors Will Love Insulet (PODD)

2025-12-22zacks.com

Why Insulet (PODD) is a Top Growth Stock for the Long-Term

2025-12-10zacks.com

Here is Why Growth Investors Should Buy Insulet (PODD) Now

2025-11-24zacks.com

Looking for a Growth Stock? 3 Reasons Why Insulet (PODD) is a Solid Choice

2025-11-20seekingalpha.com

Insulet Corporation (PODD) Analyst/Investor Day Transcript

2025-11-13zacks.com

Insulet Stock Up Post Q3 Earnings & Revenue Beat, Margins Expand

2025-11-13zacks.com

New Strong Buy Stocks for Nov. 13: PODD, PRAA, and More

2025-11-12forbes.com

PODD Vs. Intuitive Surgical: This Underdog Might Just Win

2025-11-07zacks.com

3 Reasons Why Growth Investors Shouldn't Overlook Insulet (PODD)
More information for subscribed users:
detailed calculation of
Fundamental value created in LTM

Financial reporting

Income Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol PODD PODD PODD PODD PODD PODD PODD PODD PODD PODD PODD PODD PODD PODD
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-06 2025-08-07 2024-11-08 2024-08-09 2024-05-10 2023-11-03 2023-08-09 2023-05-05 2022-11-04
acceptedDate 2025-11-06 16:25:43 2025-08-07 16:04:35 2025-02-20 17:36:54 2024-11-07 17:41:11 2024-08-08 17:50:44 2024-05-09 17:55:06 2024-02-22 17:49:33 2023-11-02 17:45:24 2023-08-08 17:53:32 2023-05-04 17:52:25 2023-02-23 18:36:18 2022-11-03 17:46:14 2022-02-23 18:06:58 2021-02-23 17:55:47
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
revenue 706M 649M 2 072M 373M 489M 442M 1 697M 433M 397M 358M 1 305M 341M 1 099M 904M
costOfRevenue 196M 197M 626M -5M 154M 132M 537M 139M 132M 118M 500M 153M 347M 322M
grossProfit 510M 452M 1 446M 377M 334M 310M 1 160M 293M 265M 241M 806M 188M 752M 582M
grossProfitRatio 0.722 0.697 1.012 0.684 0.702 0.678 0.668 0.672 0.553
researchAndDevelopmentExpenses 77M 73M 220M 55M 54M 50M 205M 58M 55M 50M 180M 45M 160M 147M
generalAndAdministrativeExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingAndMarketingExpenses 0 0 0 0 0 0 0 0 0 0 0 0 0 0
sellingGeneralAndAdministrativeExpenses 315M 258M 917M 234M 220M 197M 735M 181M 179M 163M 588M 140M 466M 384M
otherExpenses 0 0 0 0 -6M -6M 0 700 000 -200 000 -200 000 0 0 0 0
operatingExpenses 392M 331M 1 137M 289M 280M 253M 940M 239M 234M 213M 768M 185M 626M 531M
costAndExpenses 589M 528M 1 763M 285M 434M 385M 1 477M 378M 365M 330M 1 268M 338M 973M 853M
interestIncome 9M 10M 40M 11M 9M 9M 29M 9M 7M 7M 9M 2M 500 000 3M
interestExpense 16M 20M 43M 12M 11M 11M 36M 2M 2M 3M 36M 7M 62M 48M
depreciationAndAmortization 22M 22M 81M 21M 19M 19M 73M 700 000 -200 000 17M 63M 16M 57M 55M
ebitda 160M 70M 424M 117M 81M 76M 324M 56M 31M 28M 109M 1M 140M 110M
ebitdaratio 0.227 0.108 0.313 0.151 0.171 0.128 0.078 0.077 0.003
operatingIncome 118M 121M 309M 88M 55M 57M 220M 55M 31M 10M 38M -15M 126M 52M
operatingIncomeRatio 0.167 0.187 0.236 0.112 0.129 0.127 0.078 0.029 -0.043
totalOtherIncomeExpensesNet 5M -93M -9M -5M -4M -2M -5M 700 000 -200 000 14M -28M 9M -106M -42M
incomeBeforeTax 123M 28M 300M 83M 51M 55M 215M 54M 29M 25M 10M -6M 21M 10M
incomeBeforeTaxRatio 0.174 0.044 0.222 0.105 0.124 0.124 0.072 0.069 -0.017
incomeTaxExpense 35M 6M -118M 5M -138M 3M 8M 2M 1M 800 000 5M -500 000 4M 3M
netIncome 88M 23M 418M 78M 189M 52M 206M 52M 27M 24M 5M -5M 17M 7M
netIncomeRatio 0.124 0.035 0.208 0.386 0.117 0.12 0.069 0.066 -0.015
eps 1.24 0.32 5.97 1.14 2.73 0.74 2.96 0.74 0.39 0.34 0.066 -0.075 0.25 0.11
epsdiluted 1.24 0.32 1.08 2.59 0.73 0.7 0.39 0.34 -0.075
weightedAverageShsOut 71M 70M 70M 70M 70M 70M 70M 70M 70M 70M 69M 69M 68M 65M
weightedAverageShsOutDil 71M 71M 74M 74M 74M 74M 74M 74M 70M 70M 70M 69M 69M 66M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-21 2024-02-23 2023-02-24 2022-02-24 2021-02-24
fiscalYear 2024 2023 2022 2021 2020
netInterestIncome -3M -8M -27M -61M -45M
ebit 343M 251M 46M 82M 55M
nonOperatingIncomeExcludingInterest -34M -31M -8M 44M -3M
netIncomeFromContinuingOperations 418M 206M 5M 17M 7M
netIncomeFromDiscontinuedOperations 0 0 0 0 0
otherAdjustmentsToNetIncome 0 0 0 0 0
netIncomeDeductions 0 0 0 0 0
bottomLineNetIncome 418M 206M 5M 17M 7M
epsDiluted 5.78 2.94 0.066 0.25 0.1

Balance Sheet Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol PODD PODD PODD PODD PODD PODD PODD PODD PODD PODD PODD PODD PODD PODD
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-06 2025-08-07 2024-11-08 2024-08-09 2024-05-10 2023-11-03 2023-08-09 2023-05-05 2022-11-04
acceptedDate 2025-11-06 16:25:43 2025-08-07 16:04:35 2025-02-20 17:36:54 2024-11-07 17:41:11 2024-08-08 17:50:44 2024-05-09 17:55:06 2024-02-22 17:49:33 2023-11-02 17:45:24 2023-08-08 17:53:32 2023-05-04 17:52:25 2023-02-23 18:36:18 2022-11-03 17:46:14 2022-02-23 18:06:58 2021-02-23 17:55:47
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
cashAndCashEquivalents 757M 993M 953M 903M 716M 697M 651M 685M 660M 621M 624M 722M 792M 907M
shortTermInvestments 0 129M 0 0 106M 54M 54M 105M 0 0 51M 0 0 40M
cashAndShortTermInvestments 757M 1 122M 953M 903M 821M 751M 704M 685M 660M 621M 675M 722M 792M 948M
netReceivables 462M 445M 366M 262M 349M 321M 360M 270M 251M 217M 206M 201M 161M 84M
inventory 446M 447M 430M 445M 431M 431M 403M 411M 411M 386M 347M 328M 303M 154M
otherCurrentAssets 194M 244M 122M 252M 131M 99M 100M 105M 100M 106M 72M 78M 61M 52M
totalCurrentAssets 1 859M 2 257M 1 871M 1 861M 1 731M 1 602M 1 566M 1 471M 1 422M 1 330M 1 299M 1 329M 1 317M 1 238M
propertyPlantEquipmentNet 724M 720M 760M 703M 678M 668M 693M 649M 602M 597M 626M 553M 546M 494M
goodwill 52M 52M 52M 52M 52M 52M 52M 52M 52M 52M 52M 52M 40M 40M
intangibleAssets 105M 102M 99M 100M 99M 99M 99M 100M 100M 100M 76M 54M 37M 29M
goodwillAndIntangibleAssets 157M 154M 150M 151M 150M 150M 150M 151M 151M 152M 127M 105M 76M 69M
longTermInvestments 19M 19M 6M 0 0 38M 0 31M 0 0 15M 0 19M 15M
taxAssets 101M 0 142M 144M 141M -38M 0 -31M 0 0 0 0 0 0
otherNonCurrentAssets 169M 319M 159M 166M 181M 205M 179M 196M 212M 211M 184M 179M 90M 58M
totalNonCurrentAssets 1 170M 1 212M 1 216M 1 165M 1 151M 1 022M 1 022M 997M 964M 959M 952M 837M 732M 635M
otherAssets 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalAssets 3 029M 3 469M 3 088M 3 025M 2 882M 2 624M 2 588M 2 468M 2 386M 2 289M 2 251M 2 166M 2 049M 1 873M
accountPayables 48M 96M 20M 40M 77M 76M 19M 78M 108M 86M 31M 62M 38M 54M
shortTermDebt 96M 478M 86M 42M 38M 39M 53M 50M 29M 28M 31M 27M 30M 21M
taxPayables 0 0 0 0 0 0 0 0 0 0 0 0 0 5M
deferredRevenue 17M 17M 12M 0 22M 18M 15M 14M 0 0 16M 0 4M 5M
otherCurrentLiabilities 487M 418M 268M 424M 349M 299M 242M 310M 288M 270M 191M 245M 87M 75M
totalCurrentLiabilities 648M 1 010M 528M 506M 486M 432M 451M 451M 425M 383M 365M 334M 229M 208M
longTermDebt 935M 939M 1 296M 1 356M 1 360M 1 363M 1 366M 1 371M 1 369M 1 369M 1 374M 1 380M 1 249M 1 044M
deferredRevenueNonCurrent 2M 1M 2M 0 2M 2M 2M 2M 0 0 2M 0 2M 1 000 000
deferredTaxLiabilitiesNonCurrent 0 0 0 0 0 0 0 -2M 0 0 0 0 0 0
otherNonCurrentLiabilities 63M 56M 10M 45M 35M 36M 7M 38M 38M 34M 7M 1 315M 6M 5M
totalNonCurrentLiabilities 998M 996M 1 348M 1 401M 1 397M 1 401M 1 404M 1 409M 1 407M 1 403M 1 410M 1 404M 1 264M 1 062M
otherLiabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0
capitalLeaseObligations 0 0 40M 0 0 0 30M 56M 0 0 27M 0 8M 12M
totalLiabilities 1 645M 2 006M 1 876M 1 907M 1 883M 1 833M 1 856M 1 860M 1 832M 1 786M 1 775M 1 738M 1 493M 1 269M
preferredStock 0 0 0 0 0 0 0 0 0 0 0 0 0 0
commonStock 100 000 100 000 100 000 100 000 100 000 100 000 100 000 100 000 100 000 100 000 100 000 100 000 100 000 100 000
retainedEarnings 186M 98M 40M -60M -138M -327M -378M -481M -533M -561M -584M -601M -650M -666M
accumulatedOtherComprehensiveIncomeLoss 13M 16M -13M 20M -4M -500 000 8M 8M 16M 16M 20M 7M -2M 6M
othertotalStockholdersEquity 1 185M 1 348M 1 159M 1 141M 1 118M 1 081M 1 071M 1 047M 1 022M
totalStockholdersEquity 1 384M 1 463M 1 212M 1 118M 998M 791M 733M 608M 554M 503M 476M 428M 556M 604M
totalEquity 1 384M 1 463M 1 212M 1 118M 998M 791M 733M 608M 554M 503M 476M 428M 556M 604M
totalLiabilitiesAndStockholdersEquity 3 029M 3 469M 3 025M 2 882M 2 624M 2 468M 2 386M 2 289M 2 166M
minorityInterest 0 0 0 0 0 0 0 0 0 0 0 0 0 0
totalLiabilitiesAndTotalEquity 3 029M 3 469M 3 088M 3 025M 2 882M 2 624M 2 588M 2 468M 2 386M 2 289M 2 251M 2 166M 2 049M 1 873M
totalInvestments 19M 148M 6M 0 106M 54M 54M 105M 0 0 66M 0 19M 55M
totalDebt 1 031M 1 417M 1 422M 1 398M 1 398M 1 402M 1 449M 1 420M 1 398M 1 397M 1 433M 1 407M 1 287M 1 076M
netDebt 274M 425M 469M 496M 682M 705M 798M 735M 738M 776M 809M 685M 495M 169M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-21 2024-02-23 2023-02-24 2022-02-24 2021-02-24
fiscalYear 2024 2023 2022 2021 2020
accountsReceivables 366M 360M 206M 161M 84M
otherReceivables 0 0 0 0 0
prepaids 0 0 0 0 0
totalPayables 20M 19M 31M 38M 54M
otherPayables 0 0 0 0 0
accruedExpenses 143M 122M 96M 70M 53M
capitalLeaseObligationsCurrent 0 0 0 0 0
capitalLeaseObligationsNonCurrent 40M 30M 27M 8M 12M
treasuryStock 0 0 0 0 0
additionalPaidInCapital 1 184M 1 103M 1 041M 1 208M 1 264M
otherTotalStockholdersEquity 0 0 0 0 0

Cash Flow Statement

Property 2025 q3 2025 q2 2024 q4 2024 q3 2024 q2 2024 q1 2023 q4 2023 q3 2023 q2 2023 q1 2022 q4 2022 q3 2021 q4 2020 q4
date 2025-09-30 2025-06-30 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2021-12-31 2020-12-31
symbol PODD PODD PODD PODD PODD PODD PODD PODD PODD PODD PODD PODD PODD PODD
reportedCurrency USD USD USD USD USD USD USD USD USD USD USD USD USD USD
cik 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M 1M
fillingDate 2025-11-06 2025-08-07 2024-11-08 2024-08-09 2024-05-10 2023-11-03 2023-08-09 2023-05-05 2022-11-04
acceptedDate 2025-11-06 16:25:43 2025-08-07 16:04:35 2025-02-20 17:36:54 2024-11-07 17:41:11 2024-08-08 17:50:44 2024-05-09 17:55:06 2024-02-22 17:49:33 2023-11-02 17:45:24 2023-08-08 17:53:32 2023-05-04 17:52:25 2023-02-23 18:36:18 2022-11-03 17:46:14 2022-02-23 18:06:58 2021-02-23 17:55:47
calendarYear 2025 2025 2024 2024 2024 2023 2023 2023 2022
period Q3 Q2 FY Q3 Q2 Q1 FY Q3 Q2 Q1 FY Q3 FY FY
netIncome 88M 23M 418M 78M 189M 52M 206M 52M 27M 24M 5M -5M 17M 7M
depreciationAndAmortization 22M 22M 81M 21M 19M 19M 73M 19M 18M 17M 63M 16M 57M 55M
deferredIncomeTax 43M 0 -137M -2M -139M 0 500 000 14M 1M 0 -1 000 000 0 0 0
stockBasedCompensation 17M 8M 69M 18M 17M 14M 48M 11M 13M 12M 41M 9M 34M 36M
changeInWorkingCapital -33M 53M -17M -5M 5M -200 000 -191M -26M -17M -56M -3M 34M -264M -63M
accountsReceivables 24M -34M -10M -29M -28M 37M -154M -22M -33M -12M -52M 600 000 -71M -14M
inventory -23M 2M -32M -8M -700 000 -30M -54M -3M -25M -38M -49M -11M -154M -51M
accountsPayables -47M 36M 2M -36M 900 000 56M -11M -33M 23M 52M -2M 3M -16M 7M
otherWorkingCapital 13M 49M 24M 69M 33M -63M 28M 32M 18M -57M 101M 41M -22M -6M
otherNonCashItems -10M 91M 16M -12M 6M -7M 8M -14M 1M 3M 14M 3M 87M 49M
netCashProvidedByOperatingActivities 126M 197M 430M 99M 97M 88M 146M 56M 44M 500 000 119M 57M -68M 84M
investmentsInPropertyPlantAndEquipment -18M -23M -134M -22M -25M -24M -109M -22M -18M -37M -157M -34M -123M -167M
acquisitionsNet 0 0 0 0 0 0 -3M 0 0 -3M -26M 0 0 0
purchasesOfInvestments 0 0 -12M 0 0 0 -7M -200 000 -5M -2M -8M 0 0 -38M
salesMaturitiesOfInvestments 0 0 0 0 0 0 0 0 0 29M 0 0 40M 218M
otherInvestingActivites -13M 0 -7M 0 -2M -3M 0 -29M 0
netCashUsedForInvestingActivites -31M -23M -29M -25M -24M -23M -23M -42M -34M
debtRepayment -519M -382M 8M -7M -15M -7M -7M -7M -6M
commonStockIssued 0 -6M -13M 7M 6M 100 000 0 6M 0
commonStockRepurchased -30M -30M 0 11M 0 -5M 0 -200 000 0 0 0 0 0 0
dividendsPaid 0 0 0 0 0 0 0 0 0
otherFinancingActivites 91M 74M -100 000 -1M -5M 100 000 10M -11M 2M
netCashUsedProvidedByFinancingActivities -457M -344M 8M -900 000 -14M -7M 3M -12M -4M
effectOfForexChangesOnCash -2M 9M -7M 5M -900 000 -3M 2M -1M 100 000 -100 000 -4M -6M -6M 5M
netChangeInCash -364M -162M 249M 187M 19M 46M 15M 25M 24M -54M -117M 13M -116M 708M
cashAtEndOfPeriod 757M 1 122M 953M 903M 716M 697M 704M 685M 660M 636M 690M 737M 806M 922M
cashAtBeginningOfPeriod 1 122M 1 283M 704M 716M 697M 651M 690M 660M 636M 690M 806M 724M 922M 214M
operatingCashFlow 126M 197M 430M 99M 97M 88M 146M 56M 44M 500 000 119M 57M -68M 84M
capitalExpenditure -21M -23M -125M -22M -25M -24M -76M -22M -18M -37M -157M -34M -123M -167M
freeCashFlow 105M 173M 305M 76M 72M 64M 70M 34M 26M -37M -38M 23M -191M -83M
link Link Link Link Link Link Link Link Link Link
finalLink Link Link Link Link Link Link Link Link Link
filingDate 2025-02-21 2024-02-23 2023-02-24 2022-02-24 2021-02-24
fiscalYear 2024 2023 2022 2021 2020
otherInvestingActivities 0 0 0 0 0
netCashProvidedByInvestingActivities -146M -119M -191M -83M 14M
netDebtIssuance -41M -27M -40M 49M 127M
longTermNetDebtIssuance -41M -27M -40M 49M 127M
shortTermNetDebtIssuance 0 0 0 0 0
netStockIssuance 20M 27M 16M 24M 509M
netCommonStockIssuance 20M 27M 16M 24M 509M
commonStockIssuance 20M 27M 16M 24M 509M
netPreferredStockIssuance 0 0 0 0 0
netDividendsPaid 0 0 0 0 0
commonDividendsPaid 0 0 0 0 0
preferredDividendsPaid 0 0 0 0 0
otherFinancingActivities -8M -14M -17M -32M -30M
netCashProvidedByFinancingActivities -28M -14M -40M 41M 606M
incomeTaxesPaid 0 8M 6M 7M 3M
interestPaid 0 50M 34M 22M 3M

Earning call transcript

2025 q3
2025-11-06 ET (fiscal 2025 q3)
2025 q2
2025-08-07 ET (fiscal 2025 q2)
2025 q1
2025-05-08 ET (fiscal 2025 q1)
2024 q4
2025-02-20 ET (fiscal 2024 q4)
2024 q3
2024-11-07 ET (fiscal 2024 q3)
2024 q2
2024-08-08 ET (fiscal 2024 q2)
2024 q1
2024-05-09 ET (fiscal 2024 q1)
2023 q4
2024-02-22 ET (fiscal 2023 q4)
2023 q3
2023-11-02 ET (fiscal 2023 q3)
2023 q2
2023-08-08 ET (fiscal 2023 q2)
2023 q1
2023-05-04 ET (fiscal 2023 q1)
2022 q4
2023-02-23 ET (fiscal 2022 q4)
2022 q3
2022-11-03 ET (fiscal 2022 q3)
2022 q2
2022-08-07 ET (fiscal 2022 q2)
2022 q1
2022-05-06 ET (fiscal 2022 q1)

SEC forms

Show financial reports only

SEC form 10
2025-11-06 16:25 ET
Insulet reported for 2025 q3
SEC form 8
2025-11-06 07:11 ET
Insulet published news for 2025 q3
SEC form 8
2025-11-06 07:11 ET
Insulet published news for 2025 q3
SEC form 10
2025-08-07 20:04 ET
Insulet reported for 2025 q2
SEC form 8
2025-08-07 11:03 ET
Insulet published news for 2025 q2
SEC form 8
2025-08-07 11:03 ET
Insulet published news for 2025 q2
SEC form 10
2025-05-09 00:00 ET
Insulet published news for 2025 q1
SEC form 10
2025-05-08 21:41 ET
Insulet published news for 2025 q1
SEC form 8
2025-05-08 20:02 ET
Insulet published news for 2025 q1
SEC form 8
2025-05-08 20:02 ET
Insulet reported for 2025 q1
SEC form 8
2025-03-18 21:10 ET
Insulet published news for 2024 q4
SEC form 8
2025-03-18 21:10 ET
Insulet published news for 2024 q4
SEC form 8
2025-03-18 11:49 ET
Insulet published news for 2024 q4
SEC form 8
2025-03-18 11:49 ET
Insulet published news for 2024 q4
SEC form 8
2025-03-10 10:35 ET
Insulet published news for 2024 q4
SEC form 8
2025-03-10 10:35 ET
Insulet published news for 2024 q4
SEC form 10
2025-02-21 00:00 ET
Insulet published news for 2024 q4
SEC form 10
2025-02-20 22:36 ET
Insulet published news for 2024 q4
SEC form 8
2025-02-20 16:04 ET
Insulet published news for 2024 q4
SEC form 8
2025-02-20 16:04 ET
Insulet reported for 2024 q4
SEC form 10
2024-11-07 17:41 ET
Insulet reported for 2024 q3
SEC form 8
2024-11-07 16:03 ET
Insulet published news for 2024 q3
SEC form 8
2024-11-07 16:03 ET
Insulet published news for 2024 q3
SEC form 10
2024-08-09 00:00 ET
Insulet published news for 2024 q2
SEC form 10
2024-08-08 17:50 ET
Insulet reported for 2024 q2
SEC form 8
2024-08-08 16:03 ET
Insulet published news for 2024 q2
SEC form 8
2024-08-08 16:03 ET
Insulet published news for 2024 q2
SEC form 8
2024-07-26 00:00 ET
Insulet published news for 2024 q2
SEC form 8
2024-07-26 00:00 ET
Insulet published news for 2024 q2
SEC form 10
2024-05-10 00:00 ET
Insulet published news for 2024 q1
SEC form 8
2024-05-09 00:00 ET
Insulet published news for 2024 q1
SEC form 8
2024-05-09 00:00 ET
Insulet published news for 2024 q1
SEC form 10
2024-02-23 00:00 ET
Insulet published news for 2023 q4
SEC form 10
2024-02-22 17:49 ET
Insulet published news for 2023 q4
SEC form 8
2024-02-22 16:08 ET
Insulet published news for 2023 q4
SEC form 8
2024-02-22 16:08 ET
Insulet reported for 2023 q4
SEC form 10
2023-11-03 00:00 ET
Insulet published news for 2023 q3
SEC form 10
2023-11-02 17:45 ET
Insulet published news for 2023 q3
SEC form 8
2023-11-02 16:03 ET
Insulet reported for 2023 q3
SEC form 10
2023-08-09 00:00 ET
Insulet published news for 2023 q2
SEC form 10
2023-08-08 17:53 ET
Insulet published news for 2023 q2
SEC form 6
2023-08-08 16:03 ET
Insulet reported for 2023 q2
SEC form 6
2023-08-08 08:01 ET
Insulet published news for 2023 q2
SEC form 8
2023-08-08 00:00 ET
Insulet published news for 2023 q2
SEC form 6
2023-06-12 08:07 ET
Insulet published news for 2023 q1
SEC form 6
2023-06-07 16:02 ET
Insulet published news for 2023 q1
SEC form 10
2023-05-05 00:00 ET
Insulet published news for 2023 q1
SEC form 8
2023-05-04 00:00 ET
Insulet reported for 2023 q1
SEC form 6
2023-02-24 15:18 ET
Insulet published news for 2022 q4
SEC form 10
2023-02-24 00:00 ET
Insulet reported for 2022 q4
SEC form 10
2023-02-23 18:36 ET
Insulet reported for 2022 q4
SEC form 6
2023-02-23 16:03 ET
Insulet published news for 2022 q4
SEC form 8
2023-02-23 00:00 ET
Insulet reported for 2022 q4
SEC form 6
2023-02-22 07:02 ET
Insulet published news for 2022 q4
SEC form 6
2023-02-14 07:01 ET
Insulet published news for 2022 q4
SEC form 6
2022-12-14 16:03 ET
Insulet published news for 2022 q3
SEC form 6
2022-12-01 08:29 ET
Insulet published news for 2022 q3
SEC form 6
2022-11-14 16:33 ET
Insulet published news for 2022 q3
SEC form 10
2022-11-04 00:00 ET
Insulet reported for 2022 q3
SEC form 10
2022-11-03 17:46 ET
Insulet reported for 2022 q3
SEC form 6
2022-11-03 16:02 ET
Insulet published news for 2022 q3
SEC form 8
2022-11-03 00:00 ET
Insulet reported for 2022 q3
SEC form 6
2022-10-17 08:30 ET
Insulet published news for 2022 q3
SEC form 6
2022-09-27 08:57 ET
Insulet published news for 2022 q2
SEC form 10
2022-08-05 00:00 ET
Insulet reported for 2022 q2
SEC form 10
2022-08-04 17:43 ET
Insulet reported for 2022 q2
SEC form 6
2022-08-04 16:04 ET
Insulet published news for 2022 q2
SEC form 8
2022-08-04 00:00 ET
Insulet reported for 2022 q2
SEC form 6
2022-07-11 07:26 ET
Insulet published news for 2022 q2
SEC form 6
2022-06-15 18:46 ET
Insulet published news for 2022 q1
SEC form 6
2022-05-27 16:04 ET
Insulet published news for 2022 q1
SEC form 10
2022-05-06 00:00 ET
Insulet reported for 2022 q1
SEC form 6
2022-05-05 18:11 ET
Insulet published news for 2022 q1
SEC form 10
2022-05-05 17:55 ET
Insulet reported for 2022 q1
SEC form 6
2022-05-05 16:05 ET
Insulet published news for 2022 q1
SEC form 8
2022-05-05 00:00 ET
Insulet reported for 2022 q1
SEC form 6
2022-04-12 16:00 ET
Insulet published news for 2022 q1
SEC form 6
2022-03-01 16:02 ET
Insulet published news for 2021 q4
SEC form 6
2022-02-24 16:02 ET
Insulet published news for 2021 q4
SEC form 10
2022-02-24 00:00 ET
Insulet published news for 2021 q4
SEC form 10
2022-02-23 18:06 ET
Insulet published news for 2021 q4
SEC form 6
2022-02-23 16:04 ET
Insulet published news for 2021 q4
SEC form 8
2022-02-23 00:00 ET
Insulet published news for 2021 q4
SEC form 6
2022-02-07 16:02 ET
Insulet published news for 2021 q4
SEC form 6
2022-01-28 17:41 ET
Insulet published news for 2021 q4
SEC form 10
2021-11-05 00:00 ET
Insulet published news for 2021 q3
SEC form 10
2021-11-04 17:59 ET
Insulet published news for 2021 q3
SEC form 6
2021-11-04 16:04 ET
Insulet published news for 2021 q3
SEC form 8
2021-11-04 00:00 ET
Insulet published news for 2021 q3
SEC form 6
2021-10-18 06:06 ET
Insulet published news for 2021 q3
SEC form 6
2021-10-04 16:05 ET
Insulet published news for 2021 q3
SEC form 10
2021-08-06 00:00 ET
Insulet published news for 2021 q2
SEC form 10
2021-08-05 18:04 ET
Insulet published news for 2021 q2
SEC form 6
2021-08-05 16:07 ET
Insulet published news for 2021 q2
SEC form 8
2021-08-05 00:00 ET
Insulet published news for 2021 q2
SEC form 6
2021-06-15 17:22 ET
Insulet published news for 2021 q1
SEC form 6
2021-06-01 16:08 ET
Insulet published news for 2021 q1
SEC form 6
2021-05-14 06:32 ET
Insulet published news for 2021 q1
SEC form 10
2021-05-07 00:00 ET
Insulet published news for 2021 q1
SEC form 10
2021-05-06 17:56 ET
Insulet published news for 2021 q1
SEC form 6
2021-05-06 16:04 ET
Insulet published news for 2021 q1
SEC form 8
2021-05-06 00:00 ET
Insulet published news for 2021 q1
SEC form 6
2021-05-05 08:39 ET
Insulet published news for 2021 q1
SEC form 6
2021-04-29 16:17 ET
Insulet published news for 2021 q1
SEC form 6
2021-04-19 08:02 ET
Insulet published news for 2021 q1
SEC form 6
2021-04-13 16:01 ET
Insulet published news for 2021 q1
SEC form 10
2021-02-23 17:55 ET
Insulet published news for 2020 q4
SEC form 6
2021-02-23 16:05 ET
Insulet published news for 2020 q4
SEC form 6
2021-02-19 16:05 ET
Insulet published news for 2020 q4
SEC form 6
2020-12-28 16:02 ET
Insulet published news for 2020 q3
SEC form 10
2020-11-04 18:02 ET
Insulet published news for 2020 q3
SEC form 6
2020-11-04 16:06 ET
Insulet published news for 2020 q3
SEC form 6
2020-10-20 16:03 ET
Insulet published news for 2020 q3